Medtronic received information that the day after implant of this bioprosthetic aortic heart valve, the patient exhibited dizziness and dyspnea due to transient third-degree heart block with pauses and sinus bradycardia.Temporary pacing support was provided.Three days post-implant, the patient exhibited atrial fibrillation, and was treated with medication which resulted in conversion to a sinus rhythm.Six days post-implant, the patient was symptomatic with observations of 2:1 atrio-ventricular heart block with bradycardia and complete heart block.A permanent pacemaker was implanted the following day.The patient then exhibited atrial tachycardia with ventricular response, which was successfully treated with medication.No subsequent adverse patient effects were reported.
|